A. Adamou

Improved detection of breast cancer nuclei using modular neural networks.

F. Schnorrenberg, C. Pattichis, N. Tsapatsoulis, 2000, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.

Hereditary breast and ovarian cancer in Cyprus: identification of a founder BRCA2 mutation.

A. Adamou, K. Kyriacou, S. Neuhausen, 2004, Cancer genetics and cytogenetics.

BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancer

A. Adamou, K. Kyriacou, A. Hadjisavvas, 2003, Human mutation.

Immunohistochemical versus molecular detection of RAK antigens in breast cancer.

A. Adamou, K. Kyriacou, A. Hadjisavvas, 2000, Experimental and molecular pathology.

Randomized phase III trial comparing the sequential administration of docetaxel followed by epirubicin plus cyclophosphamide versus FE75C as adjuvant chemotherapy in axillary lymph node-positive breast cancer

A. Adamou, K. Syrigos, V. Georgoulias, 2008 .

The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: a Phase II feasibility study conducted by the Hellenic Cooperative Oncology Group.

A. Adamou, G. Aravantinos, D. Skarlos, 2003, Urology.

Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II study.

A. Adamou, H. Gogas, G. Fountzilas, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

How Can We Avoid a Stroke Crisis? Working Group Report: Stroke Prevention in Patients with Atrial Fibrillation

Paulus Kirchhof, Gregory Y. H. Lip, P. Kirchhof, 2009 .

FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)

Vassilis Georgoulias, A. Adamou, D. Mavroudis, 2009, Breast Cancer Research and Treatment.

Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients

A. Adamou, M. Inbar, N. Ben-Baruch, 2003, Bone Marrow Transplantation.

Expression of p 27 KIP 1 , p 21 WAF 1 and p 53 does Not Correlate with Prognosis in Node-negative Invasive Ductal Carcinoma of the Breast

K. Kyriakou, A. Adamou, H. Gogas, 2008 .

Expression of p27KIP1, p21WAF1 and p53 does not correlate with prognosis in node-negative invasive ductal carcinoma of the breast.

K. Kyriakou, A. Adamou, H. Gogas, 2006, Anticancer research.

Adjuvant Cytotoxic and Endocrine Therapy in Pre- and Postmenopausal Patients With Breast Cancer and One to Nine Infiltrated Nodes: Five-Year Results of the Hellenic Cooperative Oncology Group Randomized HE 10/92 Study

K. Kyriakou, A. Adamou, N. Pavlidis, 2004, American journal of clinical oncology.